Otolaryngology Head and Neck Surgery Diamond Conference

Friday, April 14, 2023, 8:00 AM - Saturday, April 15, 2023, 4:00 PM CST, UAMS, Little Rock, AR


This course is designed to present health care practitioners with current information on the diagnosis and management of selected diseases commonly seen healthcare providers is the fields of Otolaryngology-Head and Neck Surgeons, Radiation Oncology, Hematology Oncology, Speech and Language Pathology and Audiology.

1. participants will be able to recognize, diagnose and plan appropriate treatment for rhinosinusitis
2. participants explain the role of surgery in the de-escalating of oropharyngeal cancer
3. participants will assess and manage patients with cochlear implants
4. Practice the current state of art in the management of oropharyngeal cancer
5. Incorporate understanding of Type 2 inflammation in treatment strategies for chronic rhinosinusitis
6. Develop algorithms for chronic rhinosinusitis management based on co-morbid conditions and biomarkers
7. Recognize the indications for bone conduction auditory implants
8. Review the current technology of bone conduction auditory devices
9. Use of percutaneous abutments for auricular prostheses

AMA PRA Category 1 Credits™ (11.50 hours), Non-Physician Attendance (11.50 hours), ANCC - American Nurses Credentialing Center (11.50 hours), AAPA - American Academy of PAs Category 1 CME (11.50 hours)

In support of improving patient care, University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

University of Arkansas for Medical Sciences Office of Continuing Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.